A Trial of the Safety, Tolerability, & Pharmacodynamics of CVL-871 in

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05389644` - TMS as a Treatment for Apathy in Alzheimer's Disease	N/A
Recruiting	`NCT06047522` - Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders	N/A
Completed	`NCT01047254` - Bupropion for the Treatment of Apathy in Alzheimer's Dementia	Phase 3
Recruiting	`NCT05561205` - rTMS for Apathy Clinical Trial	N/A

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05389644 - TMS as a Treatment for Apathy in Alzheimer's Disease

N/A

Recruiting

NCT06047522 - Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders

N/A

Completed

NCT01047254 - Bupropion for the Treatment of Apathy in Alzheimer's Dementia

Phase 3

Recruiting

NCT05561205 - rTMS for Apathy Clinical Trial

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04958031
Study type	Interventional
Source	Cerevel Therapeutics, LLC
Contact	Cerevel Clinical Trial Support
Email	cerevelclinicaltrials@cerevel.com
Status	Recruiting
Phase	Phase 2
Start date	June 22, 2021
Completion date	October 2024

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms